DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Clindamycin Phosphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 19 USDMF, 12 CEP/COS, 6 JDMF, 1 EU WC, 1 KDMF, 13 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

168 FDF Dossiers, 133 FDA Orange Book, 10 Europe, 15 Canada, 1 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML), INJECTABLE;INJECTION - EQ 150MG BASE/ML, SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - EQ 1% BASE, GEL;TOPICAL - EQ 1% BASE, GEL;TOPICAL - 5%;1.2%, GEL;TOPICAL - 5%;EQ 1% BASE, SUPPOSITORY;VAGINAL - 100MG, GEL;TOPICAL - EQ 1% BASE, CREAM;VAGINAL - EQ 2% BASE, AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 3 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 1 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 2 Finar, 7 Gangwal Chemicals, 8 Kerry, 5 Lubrizol Life Science Health, 4 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 16 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

36 Topical, 24 Solubilizers, 22 Parenteral, 21 Thickeners and Stabilizers, 16 Film Formers & Plasticizers, 14 Emulsifying Agents, 12 Fillers, Diluents & Binders, 9 Co-Processed Excipients, 9 Coating Systems & Additives, 8 Direct Compression, 8 Surfactant & Foaming Agents, 8 Controlled & Modified Release, 6 Lubricants & Glidants, 5 Taste Masking, 4 Granulation, 4 Rheology Modifiers, 3 API Stability Enhancers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 54 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 9 Finished Drug Prices

MARKET PLACE

31 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 3 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/10/2024	Sanofi	France	ROUSSELL UCLAF	13705	CLINDAMYCIN PHOSPHATE	1998-09-01	Inactive	II	N/A
28/10/2024	Sanofi	France	GENZYME CORP	13725	CLINDAMYCIN PHOSPHATE	1998-09-01	Inactive	II	N/A

Clindamycin Phosphate

Clindamycin Phosphate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

19 USDMF

12 CEP/COS

6 JDMF

1 EU WC

1 KDMF

13 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

168 FDF Dossiers

133 FDA Orange Book

10 Europe

15 Canada

1 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)

INJECTABLE;INJECTION - EQ 150MG BASE/ML

SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - EQ 1% BASE

GEL;TOPICAL - EQ 1% BASE

GEL;TOPICAL - 5%;1.2%

GEL;TOPICAL - 5%;EQ 1% BASE

SUPPOSITORY;VAGINAL - 100MG

GEL;TOPICAL - EQ 1% BASE

CREAM;VAGINAL - EQ 2% BASE

AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

3 SPI Pharma

3 DKSH

1 Jai Radhe Sales

1 Pharm-RX Chemical

2 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

13 BASF

1 BioSpectra

1 Clariant

6 Corel Pharma Chem

2 Finar

7 Gangwal Chemicals

8 Kerry

5 Lubrizol Life Science Health

4 Microlex e.U

1 Nanjing Bold Chemical

2 Pluviaendo

16 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

36 Topical

24 Solubilizers

22 Parenteral

21 Thickeners and Stabilizers

16 Film Formers & Plasticizers

14 Emulsifying Agents

12 Fillers, Diluents & Binders

9 Co-Processed Excipients

9 Coating Systems & Additives

SOLUTION;TOPICAL - EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons